Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren
3 Ergebnisse für "containing" unter Roche Glycart AG
Elecsys® IgM antitoxoplásmico
... de muestra cobas e 801 module: Serum collected using standard sampling tubes or tubes containing ... separating gel. Li‑heparin, K2‑EDTA, K3‑EDTA and Na‑citrate plasma. Plasma tubes containing separating gel ... module: Serum collected using standard sampling tubes or tubes containing separating gel. Li‑heparin, K2 ... ‑EDTA, K3‑EDTA and Na‑citrate plasma. Plasma tubes containing separating gel can be used. Volumen de ...
Elecsys® IgG antitoxoplásmico
... tubes containing separating gel. Li‑heparin, K2‑EDTA, K3‑EDTA and Na‑citrate plasma. Plasma tubes ... containing separating gel can be used. Specimen collected from living patients, blood donors, or individual ... . cobas e 801 module: Serum collected using standard sampling tubes or tubes containing separating gel ... . Li‑heparin, K2‑EDTA, K3‑EDTA and Na‑citrate plasma. Plasma tubes containing separating gel can be ...
